Clinical Trial Update: Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing nicotinamide riboside with Co-enzyme Q10 in chronic kidney disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Frailty
• Sarcopenia

Drugs mentioned

• Co-enzyme Q10 (coenzyme Q10)
• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University of Washington | Conditions: Chronic Kidney Disease, Sarcopenia | Phase 2 | Status: COMPLETED | Results posted: 2023-01-10